Related Experiment Video

Updated: Dec 24, 2025

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.1K

Mitigating yellow-fever-vaccine-associated viscerotropic disease in older travellers

Rachael Fletcher1, Hilary Simons1,2, Dipti Patel1

  • 1National Travel Health Network and Centre, London, UK.

Journal of Travel Medicine
|April 17, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.4K
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.0K

Related Experiment Videos

Last Updated: Dec 24, 2025

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
07:52

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

9.1K
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.4K
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

9.0K

Related Concept Videos

Vaccinations01:51

Vaccinations

50.9K
Overview
50.9K
Cross-reactivity00:42

Cross-reactivity

32.7K
Overview
32.7K
Methods of reducing fever01:22

Methods of reducing fever

1.1K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

119
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
119

Articles linked to this work by shared authors, journal, and citation graph.

Shared evidence, different recommendations: a comparative analysis of Qdenga (TAK-003) dengue vaccine guidance for travellers across countries.

Journal of travel medicine·2026

The Significance of Model-Based Strategies in Drug Development throughout the Lifecycle and Regulatory Decision-Making.

Current reviews in clinical and experimental pharmacology·2026

Is pre-travel advice followed? A study of UK international travellers with gastrointestinal illness and asymptomatic travellers.

Public health·2025

Parenting and COVID-19: qualitative study of educational challenges, childcare and crisis-related decision-making in diplomatic families.

BMC psychology·2025

Identifying, communicating, and de-escalating risk in high-stakes settings: How conversation analysis research can underpin communication training.

Patient education and counseling·2025

Sofosbuvir as post-exposure prophylaxis for yellow fever-associated viscerotropic disease (YEL-AVD).

The Journal of antimicrobial chemotherapy·2025

Meningitis Burden and Vaccine Impact in the WHO Western Pacific Region, 1990-2023.

Journal of travel medicine·2026

Artificial Intelligence and Complementary Digital Health Technologies Across the Travel Medicine Continuum: A Narrative Review.

Journal of travel medicine·2026

Typhoid Fever in Africa: Trends, Demographic Determinants, and Relevance to Travel Medicine.

Journal of travel medicine·2026

SEVMALrisk: An Externally Validated Clinical Risk Score for Early Risk Stratification of Severe Imported Malaria.

Journal of travel medicine·2026

Autochthonous chikungunya virus outbreak in Verona province, Italy, 2025.

Journal of travel medicine·2026

Predictors of chronic arthralgia after chikungunya virus infection: a systematic review and meta-analysis.

Journal of travel medicine·2026

The transmission-blocking dynamics of Plasmodium falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults.

Nature communications·2026

Impact of an Opioid Avoidance Protocol for ACL Reconstruction: A Pilot Sequential Cohort Study.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026

The emotional foundations of human prosociality.

Advances in child development and behavior·2026

Polygenic risk score for early identification of coronary artery disease in a real-world clinical setting within the Latvian patient population.

American heart journal plus : cardiology research and practice·2026

Associations between physical activity levels and chronic lung diseases in middle-aged and older adults in China: A CHARLS-based study.

PloS one·2026

Facilitators and barriers to adventurous play in British preschool-aged children: cross-sectional findings from the British Preschool Children's Play Survey.

BMJ public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us